![]() ![]() Chronic gastrointestinal disorders with obvious digestive and absorption disorders, as well as other endocrine diseases, such as hyperthyroidism, hypercortisolism, acromegaly, etc.Hyperlipidemia patients with irregular or unstable dose of lipid-lowering drugs.History of diabetic ketoacidosis, diabetic hyperglycemic hyperosmolar syndrome, lactic acidosis, diabetic hypoglycemia or is currently combined with retinopathy, diabetic nephropathy and diabetic neuropathy.Screening for having received anti-diabetic drug therapy within 3 months or receiving continuous anti-diabetic drug therapy at any time before screening for more than 3 months. ![]() ![]() Type 1 diabetes, gestational diabetes, or other specific types of diabetes.Be able to understand the procedures and methods of this clinical study, voluntarily participate in and sign the informed consent.HbA1c 7% to 10%, and fasting venous plasma glucose ≤ 15 mmol/L.Patients with type 2 diabetes whose blood glucose is not well controlled after diet control and exercise therapy for more than 3 months.Diagnosed as type 2 diabetes according to the diagnostic criteria of type 2 diabetes established by WHO in 1999.Aged 18-75 years old and gender of both sex.Why Should I Register and Submit Results?. ![]()
0 Comments
Leave a Reply. |